Fresh analysis suggests that people who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy tend to recover shed pounds much more quickly than those who halt traditional diet and exercise plans.
Published data in a prominent medical journal points out that while obese individuals often shed substantial amounts of their total mass while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals using such medications should be cognizant of the risk of fast weight regain when the medication is stopped," stated expert Dr. Susan Jebb.
That rate of recovery suggests a reversion to pre-treatment weight within about one and a half years.
Analyzing Therapies
The research, which looked at 37 of studies involving over 9,000 of participants, compared the outcomes of GLP-1 agonists with conventional dieting.
Scientists note that individuals who lose weight through lifestyle changes alone usually have a more gradual creep back—perhaps 0.1 kg a month—after stopping.
Explaining the Rapid Rebound
Nutrition scientists believe the way of the drugs is key to understanding the heightened rebound.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of GLP-1 concentrations far above than normal might result in the body to produce less of its endogenous hormone, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Stopping of this GLP-1 'fix' leads to appetite is no longer kept in check, making binge eating much more probable."
A Lifelong Condition?
The NHS suggest the injections for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
Professionals contend that, due to the high risk of relapse, the treatment should be considered long-term.
This view is reinforced by drug manufacturers, who state that the findings "highlight the chronic nature of excess weight," similar to managing diseases like high blood pressure.
Patient Testimonies
People who have come off the jabs explain a sudden return of appetite.
"It felt as if a trigger that goes on and you become ravenous," said one woman.
The struggle is compounded if individuals have not developed sustainable dietary or behavioural modifications during treatment.
Significant Adoption
Survey data suggest that millions of people in the UK have used these injections in the past year, with desire continuing to grow.
- Adoption is more common among females compared to men.
- The middle-aged age group shows the highest level of interest.
- A large proportion access the medications through private prescriptions rather than the NHS.
In conclusion, clinicians emphasize that while GLP-1 drugs are powerful agents for shedding pounds, they are not a magic cure and lasting health benefits likely depends on integrated lifestyle management.
